Total Payments
$43,941
2024 Payments
$1,360
Companies
33
Transactions
345
Medicare Patients
3,701
Medicare Billing
$363,564
Payment Breakdown by Category
Other$27,200 (61.9%)
Food & Beverage$14,456 (32.9%)
Travel$2,103 (4.8%)
Education$182.76 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $27,200 | 14 | 61.9% |
| Food and Beverage | $14,456 | 314 | 32.9% |
| Travel and Lodging | $2,103 | 9 | 4.8% |
| Education | $182.76 | 8 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $32,005 | 70 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,697 | 34 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,700 | 10 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $995.89 | 24 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $955.96 | 19 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $752.80 | 10 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $659.84 | 23 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $549.59 | 51 | $0 (2024) |
| Esperion Therapeutics, Inc. | $360.28 | 3 | $0 (2022) |
| PFIZER INC. | $300.14 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,360 | 12 | Boehringer Ingelheim Pharmaceuticals, Inc. ($466.92) |
| 2023 | $841.25 | 7 | Boehringer Ingelheim Pharmaceuticals, Inc. ($244.16) |
| 2022 | $722.29 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($249.04) |
| 2021 | $464.22 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($253.12) |
| 2020 | $517.03 | 6 | AstraZeneca Pharmaceuticals LP ($212.88) |
| 2019 | $5,982 | 22 | Amgen Inc. ($5,062) |
| 2018 | $13,948 | 74 | Amgen Inc. ($10,438) |
| 2017 | $20,107 | 211 | Amgen Inc. ($15,500) |
All Payment Transactions
345 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $119.80 | General |
| Category: DIABETES | ||||||
| 11/13/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $124.23 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $92.63 | General |
| 09/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $90.74 | General |
| 08/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 06/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $111.39 | General |
| Category: Cardiology | ||||||
| 06/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $119.99 | General |
| Category: DIABETES | ||||||
| 05/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $128.08 | General |
| Category: Diabetes | ||||||
| 03/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $102.13 | General |
| Category: DIABETES | ||||||
| 03/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $123.91 | General |
| Category: Cardiovascular | ||||||
| 02/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $120.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $101.47 | General |
| Category: Cardiology | ||||||
| 10/18/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: DIABETES | ||||||
| 10/12/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $121.29 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/18/2023 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $135.11 | General |
| Category: Pacemakers | ||||||
| 06/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $119.36 | General |
| Category: DIABETES | ||||||
| 06/09/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $105.90 | General |
| Category: Cardiology | ||||||
| 05/24/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/24/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $109.79 | General |
| Category: Cardiology | ||||||
| 12/07/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiology | ||||||
| 11/10/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $105.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/19/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $100.76 | General |
| Category: Cardiology | ||||||
| 08/09/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.24 | General |
| Category: DIABETES | ||||||
| 05/13/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Education | In-kind items and services | $10.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/06/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Education | In-kind items and services | $10.85 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 701 | 990 | $244,052 | $71,436 |
| 2022 | 6 | 947 | 1,416 | $365,095 | $102,813 |
| 2021 | 8 | 1,045 | 1,434 | $373,547 | $107,165 |
| 2020 | 9 | 1,008 | 1,292 | $316,564 | $82,149 |
Total Patients
3,701
Total Services
5,132
Medicare Billing
$363,564
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 390 | 653 | $175,004 | $61,987 | 35.4% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 45 | 50 | $25,600 | $2,604 | 10.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 46 | 46 | $18,814 | $2,509 | 13.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 191 | 209 | $18,810 | $2,247 | 11.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 32 | $5,824 | $2,089 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 461 | 891 | $238,788 | $85,806 | 35.9% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2022 | 127 | 136 | $69,632 | $8,030 | 11.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 268 | 295 | $26,550 | $3,303 | 12.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 51 | 51 | $20,859 | $2,735 | 13.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 27 | $4,914 | $1,643 | 33.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $4,352 | $1,296 | 29.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 461 | 822 | $220,296 | $80,146 | 36.4% |
| 93224 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg, includes recording, scanning analysis with report | Office | 2021 | 140 | 144 | $73,728 | $8,861 | 12.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 37 | 39 | $14,040 | $5,959 | 42.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 267 | 285 | $25,650 | $3,316 | 12.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 48 | $8,736 | $3,005 | 34.4% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2021 | 51 | 51 | $20,859 | $2,814 | 13.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 31 | 31 | $8,432 | $2,763 | 32.8% |
| 93272 | Heart rhythm symptom-related interpretation of 24-hour ekg monitoring up to 30 days | Office | 2021 | 14 | 14 | $1,806 | $301.00 | 16.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 426 | 683 | $183,044 | $54,218 | 29.6% |
| 93224 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg | Office | 2020 | 101 | 105 | $53,760 | $6,801 | 12.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 71 | 74 | $10,360 | $6,607 | 63.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 31 | 34 | $12,240 | $3,898 | 31.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 254 | 266 | $23,940 | $3,672 | 15.3% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2020 | 43 | 43 | $17,587 | $2,089 | 11.9% |
About Dr. Manuel Pun, MD
Dr. Manuel Pun, MD is a Cardiovascular Disease healthcare provider based in Trumbull, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1205833167.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manuel Pun, MD has received a total of $43,941 in payments from pharmaceutical and medical device companies, with $1,360 received in 2024. These payments were reported across 345 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($27,200).
As a Medicare-enrolled provider, Pun has provided services to 3,701 Medicare beneficiaries, totaling 5,132 services with total Medicare billing of $363,564. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Trumbull, CT
- Active Since 07/06/2005
- Last Updated 11/14/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1205833167
Products in Payments
- Repatha (Biological) $31,672
- JARDIANCE (Drug) $2,529
- ENTRESTO (Drug) $995.89
- PRALUENT ALIROCUMAB INJECTION (Biological) $670.18
- XARELTO (Drug) $659.84
- FARXIGA (Drug) $511.41
- BRILINTA (Drug) $458.22
- ELIQUIS (Drug) $455.99
- PRADAXA (Drug) $419.81
- NEXLIZET (Drug) $360.28
- Vascepa (Drug) $279.54
- VERQUVO (Drug) $252.58
- PRALUENT (Drug) $226.54
- LifeVest (Device) $181.98
- Corlanor (Drug) $155.03
- CHANTIX (Drug) $148.54
- OPSUMIT MACITENTAN (Drug) $143.31
- Livalo (Drug) $137.14
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $136.83
- MICRA (Device) $135.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Trumbull
Dr. Robert Jumper, Md, MD
Cardiovascular Disease — Payments: $15,657
Cardiovascular Disease $15,657
David Lorenz, M.d, M.D
Cardiovascular Disease — Payments: $15,579
Cardiovascular Disease $15,579
Dr. Charles Landau, Md, MD
Cardiovascular Disease — Payments: $7,204
Cardiovascular Disease $7,204
Victor Mejia, M.d, M.D
Cardiovascular Disease — Payments: $6,852
Cardiovascular Disease $6,852
Dr. Jeffrey Berman, M.d, M.D
Cardiovascular Disease — Payments: $3,299
Cardiovascular Disease $3,299
Dr. Robert Sackstein, M.d, M.D
Cardiovascular Disease — Payments: $2,259
Cardiovascular Disease $2,259